7063-94-7

Basic information

• Product Name: 6-azepan-1-yl-1-ethyl-5-{[3-(2-methoxyethyl)-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
• CAS NO: 7063-94-7
• Molecular Formula: C₂₂H₂₈N₄O₃S₂
• Molecular Weight: 460.6127
• Mol File: 7063-94-7.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 479.1°C at 760 mmHg
• Flash Point: 243.6°C
• Density: 1.33g/cm³
• Vapor Pressure: 2.43E-09mmHg at 25°C
• Refractive Index: 1.647
• CAS DataBase Reference: 6-azepan-1-yl-1-ethyl-5-{[3-(2-methoxyethyl)-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 6-azepan-1-yl-1-ethyl-5-{[3-(2-methoxyethyl)-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile(7063-94-7)
• EPA Substance Registry System: 6-azepan-1-yl-1-ethyl-5-{[3-(2-methoxyethyl)-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile(7063-94-7)

Safety Data

• Hazardous Substances Data: 7063-94-7(Hazardous Substances Data)

Upstream product

• 689-97-4 3-buten-1-yne 
• 683-58-9 acetohydroximoyl chloride 

Downstream Products

• 7064-16-6 3-Methyl-5--2-isoxazolin 

Relevant articles and documents

AN IMPROVED PROCEDURE FOR THE PREPARATION OF 2-ISOXAZOLINES

Aldoximes were converted in high yields by N-Chlorosuccinimide into hydroxamic acid chlorides, and corresponding nitrile oxides generated by addition of triethylamine at 40-50 deg C underwent 1,3-dipolar addition to alkenes, giving 2-isoxazolines.The whole procedure could be performed as a one-pot reaction.Oximes with other functions, sensitive to free chlorine could be converted selectively into hydroxamic acid chlorides by this procedure.Isopropylidene glyceraldoxime was added to acrolein diethylacetal thus affording an entrance to carbohydrate synthesis but the stereospecificity of the reaction is low. 2:3, 5:6-Di-O-isopropylidene-D- mannose oxime was converted to the N-hydroximinolactone by treatment with NCS and base.